NO985891L - Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler - Google Patents

Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler

Info

Publication number
NO985891L
NO985891L NO985891A NO985891A NO985891L NO 985891 L NO985891 L NO 985891L NO 985891 A NO985891 A NO 985891A NO 985891 A NO985891 A NO 985891A NO 985891 L NO985891 L NO 985891L
Authority
NO
Norway
Prior art keywords
anticonvulsants
benzamide derivatives
substituted benzamide
relates
compounds
Prior art date
Application number
NO985891A
Other languages
English (en)
Other versions
NO985891D0 (no
Inventor
John David Harling
Barry Sidney Orlek
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612608.1A external-priority patent/GB9612608D0/en
Priority claimed from GBGB9615352.3A external-priority patent/GB9615352D0/en
Priority claimed from GBGB9711013.4A external-priority patent/GB9711013D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO985891D0 publication Critical patent/NO985891D0/no
Publication of NO985891L publication Critical patent/NO985891L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen angår substituerte benzamido-heterocykliske forbindelser med den generelle formel (I). som har en alkoksysubstituent i C2-stillingen på benzamidogruppen og forskjellige substituenter i stillingene C4 og C5, idet den eventuelt er substituert på N-atomet i det heterocykliske system, og hvor den umettede ring i det heterocykliske system er en 5-, 6-, 7- eller 8-leddet ring. Oppfinnelsen angår også anvendelse av disse forbindelser som anti-konvulsjonsmidler ved visse medisinsk tilstander, og frem-gangsmåter for fremstilling av dem.P
NO985891A 1996-06-17 1998-12-16 Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler NO985891L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9612608.1A GB9612608D0 (en) 1996-06-17 1996-06-17 Novel compounds
GBGB9615352.3A GB9615352D0 (en) 1996-07-22 1996-07-22 Novel compounds
GBGB9711013.4A GB9711013D0 (en) 1997-05-28 1997-05-28 Novel compounds
PCT/EP1997/003131 WO1997048683A1 (en) 1996-06-17 1997-06-13 Substituted benzamide derivatives and their use as anticonvulsants

Publications (2)

Publication Number Publication Date
NO985891D0 NO985891D0 (no) 1998-12-16
NO985891L true NO985891L (no) 1998-12-16

Family

ID=27268330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985891A NO985891L (no) 1996-06-17 1998-12-16 Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler

Country Status (14)

Country Link
US (1) US6110934A (no)
EP (1) EP0906283A1 (no)
AR (1) AR008234A1 (no)
AU (1) AU729124B2 (no)
BR (1) BR9709906A (no)
CA (1) CA2258238A1 (no)
CZ (1) CZ416498A3 (no)
HU (1) HUP9902166A3 (no)
IL (1) IL127068A0 (no)
NO (1) NO985891L (no)
NZ (1) NZ332757A (no)
PL (1) PL330465A1 (no)
TR (1) TR199802745T2 (no)
WO (1) WO1997048683A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2446A1 (fr) * 1997-03-18 2003-01-11 Smithkline Beecham Plc Nouveaux composés
US20010016657A1 (en) 1997-03-18 2001-08-23 Smithkline Beecham P.L.C. Substituted isoquinoline derivatives and their use as anticonvulsants
TR199902283T2 (xx) * 1997-03-18 1999-12-21 Smithkline Beecham P.L.C. �kame edilmi� izokuinolin t�revleri ve bunlar�n antikonvulsant olarak kullan�m�.
GB9726695D0 (en) 1997-12-17 1998-02-18 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
GB9816984D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
GB9817424D0 (en) 1998-08-11 1998-10-07 Smithkline Beecham Plc Novel compounds
GB9915589D0 (en) * 1999-07-02 1999-09-01 Smithkline Beecham Plc Novel compounds
ES2316777T3 (es) * 2002-02-15 2009-04-16 Glaxo Group Limited Moduladores de receptores vainilloides.
GB0210762D0 (en) * 2002-05-10 2002-06-19 Glaxo Group Ltd Compounds
PT1632477T (pt) * 2003-06-12 2017-04-04 Astellas Pharma Inc Derivado de benzamida ou seu sal
MXPA06008201A (es) * 2004-01-23 2006-08-31 Amgen Inc Ligandos del receptor de vanilloide y su uso en tratamientos.
CA2645551C (en) * 2006-03-16 2016-06-28 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
EP2046787B1 (en) 2006-08-01 2011-04-06 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
CA3170064A1 (en) * 2020-04-17 2021-10-21 Marcos SAINZ Modulators of mas-related g-protein receptor x4 and related products and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634851A (no) * 1963-05-15 1900-01-01
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents

Also Published As

Publication number Publication date
WO1997048683A1 (en) 1997-12-24
HUP9902166A3 (en) 2001-01-29
AU729124B2 (en) 2001-01-25
BR9709906A (pt) 1999-08-10
NO985891D0 (no) 1998-12-16
US6110934A (en) 2000-08-29
CA2258238A1 (en) 1997-12-24
TR199802745T2 (xx) 1999-04-21
NZ332757A (en) 1999-06-29
CZ416498A3 (cs) 1999-06-16
PL330465A1 (en) 1999-05-24
AR008234A1 (es) 1999-12-29
EP0906283A1 (en) 1999-04-07
HUP9902166A2 (hu) 1999-10-28
IL127068A0 (en) 1999-09-22
AU3259597A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
NO985891L (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
HUP0001054A2 (hu) IV-típusú foszfodiészteráz inhibitor 1-aril-1,8-naftiridin-4-on-származékok
AU1282495A (en) Anthranilic acid derivative
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
DE69528005D1 (de) Prolineamid-Derivate
DK0865281T3 (da) Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler
WO2001017963A3 (en) Aminoalkoxy carbazoles and their use as 5-ht ligands
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
BR0115318A (pt) Derivados de (diidro)isoquinolina como inibidores da fosfodiesterase
EA199800170A1 (ru) Производные 2-(4-замещенного)бензиламино-2-метилпропанамида
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
DE69709933D1 (en) Aromatische amidinderivate als selektive thrombininhibitoren
HK1063785A1 (en) Substituted benzopyran derivatives against arrhythmia
TR200001452T2 (tr) Bifenilamidin türevleri.
AUPN952696A0 (en) New heterocyclic compounds
MA27143A1 (fr) Utilisation de derives de 2-amino-4- pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
EP0394471A4 (en) Thienocycloheptapyridazine compounds and medicinal uses thereof
ES2102295A1 (es) Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
SE9704770D0 (sv) New use
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
DE69400117D1 (de) Carbostyrylderivate
DK0914129T3 (da) Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler
MX9605679A (es) 3-fenilpirazoles sustituidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application